Key Statistics for TRP
|Current P/E Ratio (ttm)
Relative P/E vs.
|Earnings Per Share (INR) (ttm)
|Est. EPS (INR) (03/2014)
|Est. PEG Ratio
|Market Cap (M INR)
|Shares Outstanding (M)
|30 Day Average Volume
|Dividend Indicated Gross Yield
|Cash Dividend (INR)
|5 Year Dividend Growth
|Next Earnings Announcement
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for TRP
- Net Income (M/INR)
Torrent Pharmaceuticals Ltd. manufactures bulk drugs and pharmaceutical formulations. The Company's formulations include cardio-vascular, psychotropic and anti-biotic drugs while its bulk drugs include atenolol, ciprofloxacin and norfloxacin. Torrent Pharmaceuticals has wholly owned subsidiaries in several regulated and less regulated international markets.
More Company Profile & Key Executives for TRP
|Samir MehtaVice Chairman||R SrinivasanVP:Finance/CFO|
|Mahesh D AgrawalVP:Legal/Secy/Compliance Ofcr||Chaitanya DuttDir:Research & Development|
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.